Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
08. Januar 2025 08:00 ET
|
Liquidia Corporation
Liquidia's Chief Executive Officer, Dr. Roger Jeffs, will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025.
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update
13. November 2024 06:30 ET
|
Liquidia Corporation
Liquidia Corporation (LQDA) today reported financial results for the third quarter ended September 30, 2024.
Liquidia to Present at the Stifel 2024 Healthcare Conference
12. November 2024 08:00 ET
|
Liquidia Corporation
Liquidia Corporation (LQDA) to present at the Stifel 2024 Healthcare Conference in New York City on Tuesday, November 19, 2024, from 3:00 – 3:30 p.m. ET.
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024
06. November 2024 08:00 ET
|
Liquidia Corporation
Liquidia Corporation (LQDA) to report its third quarter 2024 financial results on November 13, 2024, via webcast at 8:30 a.m. ET
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024
04. November 2024 08:00 ET
|
Liquidia Corporation
Liquidia Corporation (NASDAQ: LQDA), to report its third quarter 2024 financial results via webcast at 8:30 a.m. ET on Friday, November 8, 2024.
Bragar Eagel & Squire, P.C. Is Investigating Liquidia, Napco, and Franklin and Encourages Investors to Contact the Firm
30. September 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Liquidia Corporation...
Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting
30. September 2024 08:00 ET
|
Liquidia Corporation
Liquidia will present a poster and host a medical theater at the CHEST 2024 annual meeting hosted by the American College of Chest Physicians this October.
Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, Centuri, Liquidia, and Elastic and Encourages Investors to Contact the Firm
16. September 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Paragon 28, Inc. (NYSE:...
Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million
16. September 2024 09:41 ET
|
Liquidia Corporation
MORRISVILLE, N.C., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia), a biopharmaceutical company developing innovative therapies for patients with rare...
LIQUIDIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm
27. August 2024 22:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Liquidia Corporation...